Delhi govt tells district admns, DoE to prepare for HPV jab roll-out | Latest News Delhi - Hindustan Times
close_game
close_game

Delhi govt tells district admns, DoE to prepare for HPV jab roll-out

By, New Delhi
Jan 20, 2023 12:26 AM IST

A senior official from the family welfare department said the Delhi government has already started conducting awareness campaigns for the prevention of cervical cancer

The Delhi government’s family welfare department on Thursday directed district administrations and the Department of Education (DoE) to submit plans for the administration of the Human Papillomavirus (HPV) vaccine in the Capital, which is expected to be launched by the Serum Institute of India (SII) by April this year, people aware of the matter said.

An HPV vaccine being administered to class 10 students in Navi Mumbai in November 2022. (HT Photo)
An HPV vaccine being administered to class 10 students in Navi Mumbai in November 2022. (HT Photo)

A senior official from the family welfare department said the Delhi government has already started conducting awareness campaigns for the prevention of cervical cancer and the importance of the HPV vaccine among girl students. However, the central government had asked states to prepare a detailed plan on the administration of the HPV vaccine.

“Our teams are already organising street plays, awareness programmes, quizzes and other interactive campaigns for school students in schools to create awareness about cervical cancer and how impactful vaccines can be for its prevention. We have now asked district administrations and the DoE to chalk out a plan on how the vaccine will be administered once it is rolled out by the central government,” the official said.

Cervical cancer is the second-most common type of cancer for women in India, and government data shows that the country contributes to the largest proportion of global cervical cancer burden. Currently, India is completely dependent on foreign manufacturers for the HPV vaccine. However, these vaccines are expensive, with each dose costing over 4,000.

In September last year, at the announcement of India’s first indigenously-developed Quadrivalent HPV (qHPV) vaccine against cervical cancer, SII’s CEO Adar Poonawalla had said that each jab is likely to be priced between 200-400.

A Delhi government official said they are also working on catching up to the Covid-19 pandemic-induced lag in routine immunisation.

“Because of the pandemic, the progress on routine immunisation was hampered because the focus was on the management of Covid, and to ensure maximum coverage of Covid vaccination. We are catching up now,” the official said.

Catch every big hit, every wicket with Crickit, a one stop destination for Live Scores, Match Stats, Infographics & much more. Explore now!

Stay updated with all top Cities including, Bengaluru, Delhi, Mumbai and more across India. Stay informed on the latest happenings in World News
SHARE THIS ARTICLE ON
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, July 18, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On